Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Gerger Armin |

Presentations at scientific and public conferences

Bonnin-Gruber, Y; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Koeberle, D; Prager, G; Stintzing, S Patient characteristics at baseline in the BERING CRC study: real-world data on BRAF V600E-mutated metastatic colorectal cancer
ONCOL RES TREAT. 2022; 45(SUPPL 2): 315-316. [Poster]
Web of Science

 

Gerger, A Pancreatic cancer and Diabetes
; Ljubljana, Slovenia. 2022. [Keynote lecture]

 

Gerger, A; Riedl, J; Hasenleithner, SO; Höfler, G; Jahn, S; Esterl, T; Jost, PJ; Speicher, MR; Heitzer, E. Identifizierung von Tumorprädispositionen im Rahmen von klinischen ctDNA-Tests
ÖGH Jahrestagung; Sep 29, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, D; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Grunberger, B; Niedersuss-Beke, D; Sandmann, M; Kasper, S; Prager, G; Stintzing, S FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab - secondary endpoint
ANN ONCOL. 2022; 33: S363-S364. Doi: 10.1016/j.annonc.2022.04.415 [Poster]
Web of Science FullText FullText_MUG

 

Klec, C; Stotz, M; Vychytilova-Faltejskova, P; Slaby, O; Gerger, A; Pichler, M ALYREF regulates glucose metabolism and tumorigenesis in colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2022. 2022; -ÖGHO Frühjahrstagung; APR 8-10, 2022; Graz, AUSTRIA. [Poster]

 

Prager, G; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Burkle, D; Von der Heyde, E; Muller-Huesmann, H; Krammer-Steiner, B; Hering-Schubert, C; Popper, U; Gerger, A; Greil, R; Reichenbach, F; Arnold, D; Fritsch, R; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Stintzing, S Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2022; 45(SUPPL 3): 64-64. [Poster]
Web of Science

 

Richtig, E; Gerger, A, Wolkersdorfer, D; Dorfinger, K; van der Mark, M; Rieder, M; Richtig, G; Greil, R. Genomic landscape of melanoma in Styria Austria-Data of the NGS Registry of the Austrian Group for Medical Tumor Therapy n(AGMT).
Jahrestagung der Österr. Gesellschaft für Dermatologie und Venerologie; Dez 1-3, 2022; Wien, Österreich. 2022. [Poster]

 

Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria. [Poster]

 

Stintzing, S; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, RM; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Prager, G Baseline characteristics of patients enrolled in the BERING CRC study: A European real-world study in BRAF V600E-mutant metastatic colorectal cancer.
J CLIN ONCOL. 2022; 40(16): E15584-E15584. [Poster]
Web of Science

 

Stintzing, S; Von Weikersthal, L; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Gruenberger, B; Niedersuess-Beke, D; Sandmann, M; Winder, T; Kasper, S; Prager, G; Heinemann, V Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab: Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114).
J CLIN ONCOL. 2022; 40(16): [Poster]
Web of Science

 

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322. [Poster]
Web of Science

 

von der Heyde, E; Burkle, D; Forstbauer, H; Hubner, G; Schmidt, B; Schroder, J; Distelrath, A; Wierecky, J; Stubs, P; Kisro, J; Welslau, M; Muller-Huesmann, H; Gohler, T; Krammer-Steiner, B; Schwaner, I; Hering-Schubert, C; Gerger, A; Greil, R; Jacobasch, L; Reichenbach, F; Stintzing, S; Prager, G Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria BERING CRC
ANN ONCOL. 2022; 33: S248-S248. Doi: 10.1016/j.annonc.2022.04.099 [Poster]
Web of Science FullText FullText_MUG

 

Koeberle, D; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; von der Heyde, E; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; Forstbauer, H; Fuxius, S; Schwaner, I; Losem, C; Hering-Schubert, C; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Prager, G; Stintzing, S Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2021; 44: 219-220.
Web of Science

 

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G, Schuuring, E; Groen, HJM; Geigl, JB; Heiter, E; Speicher, MR Harnessing circulating tumor DNA to inform clinical decisions
Festival of Genomics & Biodata 2021; JAN 26-29, 2021; London, ENGLAND. 2021. [Onlinepräsentation]

 

Seles, M; Smolle, MA; Molnar, A; Riedl, JM;, Barth, DA; Terbuch, A, Rossmann, C; Mannweiler, S; Hutterer, GC, Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, MA; gerger, A, Pichler, M; Posch, F. Metastasektomie bei metachron metastasierten Nierenzellkarzinompatient*innen - Wer, wann & wie?
73. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEp 15-18, 2021; Stuttgart, Germany. 2021. [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; Lopez-Garcia, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma
EMSOS Abstract Book. 2021; -EMSOS Annual Meeting 2021; DEC 1-3; Graz, AUSTRIA . [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; Lopez-Garcia, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Einfluss von regulatorischen T-Zellen auf die Prognose von Weichteilsarkompatienten. Retrospektive, klinisch-pathologische Studie.
Abstract-Book der Sarkomkonferenz 2021. 2021; -Sarkomkonferenz; NOV 18-20, 2021; Berlin, GERMANY. [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; Lopez-Garcia, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera J T-regulatory cells predict clinical outcome in soft tissue sarcoma patients. A clinico-pathological study
CTOS Abstract Book. 2021; -CTOS (Connective Tissue Oncology Society) - 2021 Annual Meeting; NOV 10-13; Toronto, CANADA. [Poster]

 

Stintzing, S; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Prager, G Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria - BERING CRC
ANN ONCOL. 2021; 32: S116-S116. Doi: 10.1016/j.annonc.2021.05.113 [Poster]
Web of Science FullText FullText_MUG

 

Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229. [Poster]
Web of Science

 

Terbuch, A; Absenger, G; Steinlechner, S; Mayer, M; Jost, P; Wurm, R; Wohlkönig, C; John, N; Olschewski, H; Richtig, E; Koch, L; Winder, T; Wöll, E; Gerger, A; AUTRICHE – AUsTrian Registry for Immune CHEckpoint inhibitors
Jahrestagung der DGHO; OKT 1-4, 2021; Berlin. 2021. [Poster]

 

Barth, DA; Brenner, C; Riedl, JM;Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M;Gerger, A; Pichler, M External validation of the prognostic relevance of the Advanced Lung Cancer Infammation Index (ALI) in pancreatic cancer patients
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2020. 2020; 13 (Suppl 2): 23-65.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 19-21, 2020; Vienna, AUSTRIA. [Poster]

 

Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Akhoundova, D; Maas, C; Uhlig, J; Fenchel, K; Greil, R; von der Heyde, E; Agocs, R; Weide, R; Modest, DP; Fritsch, R Retrospective analysis of treatment pathways in patients with BRAF(V600E)-mutant metastatic colorectal carcinoma - MORSECRC.
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):131-131.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. [Onlinepräsentation]
Web of Science

 

Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Liquid biopsy profiling of advanced cancer patients for clinical decision support platform analysis.
ÖGPath Frühjahrstagung 2020; SEP 11-12, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]

 

Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Seles, M; Maisel, F; Smolle, M, Molnar, S; Riedl, JM; Barth, D; Terbuch, A; Rossman, CH; Mannweiler, S; Hutterer, GC; Zigeuner, RE; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Stöger, H; Pichler, M; Posch, F Hilfestellung zur sinnvollen Indikation der Metastasektomie bei metachron metastasierten Nierenzellkarzinompatienten.
German Medical Science. 2020; -46. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; MAY, 14-16, 2020; Nuremberg, GERMANY.. [Onlinepräsentation]
FullText

 

Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA. [Poster]

 

Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

Gerger, A Präzisionsmedizin im 21. Jahrhundert
Jahrestagung der Österreichischen Gesellschaft für Klinische Pathologie und Molekularpathologie; March 8-9, 2019; Vienna, Austria. 2019. [Oral Communication]

 

Gerger, A NTRK Fusionen und Inhibition
; Vienna, Austria. 2019. [Keynote lecture]

 

Gerger, A Klinische Bedeutung der Mikrosatelliteninstabilität
Jahrestagung der Österreichischen Gesellschaft für Klinische Pathologie und Molekularpathologie; March 8-9, 2019; Vienna, Austria. 2019. [Oral Communication]

 

Mandl, J; Schmid, J; Pernthaler, B; Phlak, E; Gerger, A; Brcic, I; Kump, P; Fuchsjäger, M; Igrec, J; Value of MRI and 68Ga-DOTANOC-PET-CT in a patient with right ventricular neuroendocrine tumor
24. Jahrestagung der ÖGES gemeinsam mit der Österreichischen Schilddrüsengesellschaft und der Austrian Neuroendocrine Tumor Society; APR 24-26, 2019; Graz, AUSTRIA. 2019. [Poster]

 

Perakis, S; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Höfler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment study
The Next Generation of Clinical Trials in Molecularly Driven Therapy. 2019; -AACR; MAR 29-APR 3, 2019; Atlanta, Georgia, USA. [Oral Communication]

 

Perakis, SO; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Hoefler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment study
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-CT130 [Poster]
Web of Science FullText FullText_MUG

 

Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D; Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg. [Oral Communication]
FullText

 

Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M The influence of epithelial-mesenchymal transition on immune checkpoint molecules in biliary tract cancer
OEGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April 2019; Linz, AUSTRIA. 2019. [Poster]

 

Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN. Doi: 10.1093/annonc/mdz155.285 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, J; Stelzl, A; Aziz, F; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY . [Poster]
FullText

 

Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

Riedl, JM; Stelzl, A; Aziz, F; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz,M; Gerger, A; Sourij, H; Szkandera, J Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, Austria. 2019. [Oral Communication]

 

Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; Stöger, H; Gerger, A; Riedl, JM The AST/ALT ratio (de ritis) is an independent prognostic marker for disease free survival in stage II and III colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, AUSTRIA. 2019. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Advancing soft-tissue sarcoma aftercare using flexible parametric survival models.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualising soft tissue sarcoma aftercare with flexible parametric survival modelling.
Webabstracts of the 20th General Meeting of the International Society of Limb Salvage (ISOLS). 2019; -20th General Meeting of the International Society of Limb Salvage (ISOLS); SEP 11-14, 2019; Athens, GREECE. [Oral Communication]

 

Szkandera, J; Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, J; Stotz, M; Gerger, A; Pichler, M; Dijkstra, S; van Houdt, W; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, R Individualization of follow-up in patients with high-grade soft tissue sarcoma
CTOS; NOV 13-16, 2019; Tokyo, JAPAN. 2019. [Poster]

 

Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019. [Poster]
FullText

 

Andritsch, E; Farkas, C; Zloklikovits, S; Gerger, A; Stoger, H Meaning of personalized medicine and targeted medical therapies for patients with cancer in the context of expectations and hope
ONCOL RES TREAT. 2018; 41: 34-34. [Oral Communication]
Web of Science

 

Andritsch, E; Farkas, C; Zloklikovits, S; Gerger, A; Stöger H Importance of personalized medicine and targeted therapy for patients: Expectations and hopes
Jahrestagung DGHO; 2018; Vienna. 2018. [Oral Communication]

 

Eisterer, W; Gerger, A; Ohler, L; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Prager, G Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine
ANN ONCOL. . 2018; 29: -ESMO 20th World Congress on Gastrointestinal Cancer; JUN 20-23, 2018; Barcelona, SPAIN. [Poster]
Web of Science

 

Gerger, A Pankreskarzinom - Therapiealgorithmus
Jahrestagung der ÖGHO 20, 2018; April; 2018. [Oral Communication]

 

Gerger, A Quo vadis? Therapiekonzepte zur Behandlung des Pankreaskazinoms im Jahr 2018
Jahrestagung DGHO; Sep 28-Oct 2, 2018; Vienna. 2018. [Keynote lecture]

 

Gerger, A Neoadjuvante/ adjuvante Therapie des bei Pankreaskarzinom
DGHO Jahrestagung 2018; Sep 28-Oct 2, 2018; Vienna. 2018. [Oral Communication]

 

Gerger, A Monitoring während und nach IO Therapie
; March 2, 2018; Graz. 2018. [Oral Communication]

 

Gerger, A Pankreaskarzinom
Perceptorship Pankreaskarzinom; Vienna, Austria. 2018. [Oral Communication]

 

Gerger, A Neue Therapieoptionen beim mCRC
; Jan 8, 2018; 2018. [Oral Communication]

 

Gerger, A Chemotherapie bei Metastasen
Das kilorektale Karzinom im Wandel der zeit; Feb 15, 2018; 2018. [Oral Communication]

 

Klocker, EV; Stotz, M; Posch, F; Stojakovic, T; Stoeger, H; Kornprat, P; Gerger, A; Pichler, M A high AST/ALT (De Ritis)-Ratio represents a poor prognostic factor in a large cohort of patients with pancreatic cancer.
OeGHO Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018. [Poster]

 

Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

Pfeifer, B; Feurer, V; Maria Smolle, M; Prietl. B; Dolznig, I;Tomberger, M; Posch, F; Oberauner-Wappis, L; Ulz, C; Jacan. A; Bordag, N; Zügner, E; Magnes, C; Wuczkowski, M; Herzig, B; Stübiger, G; Hantusch, B; Kreuzthaler, M;Schulz, S; Wadsak, W; Fasching, R; Pieber, TR; Gerger, A; Brehme, M FUSION Technology - Towards Predictive Biomarkers for Relapse Risk in Stage II Colon Cancer
2nd Annual Meeting of the Austrian Platform for Personalized Medicine; OCT 11-12, 2018; Graz, AUSTRIA. 2018. [Poster]

 

Prager, G; Gerger, A; Eisterer, W; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubman, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Grunberger, B; Ohler, L Subgroup analysis in elderly patients with metastatic pancreatic cancer: Preliminary results of Austrian real world data with nab-paclitaxel/gemcitabine
ONCOL RES TREAT. 2018; 41: 125-126. [Oral Communication]
Web of Science

 

Smolle, MA; Riedl, JM; Stotz, M; Pichler, M; Kashofer, K; Gerger, A Untersuchung von 22 Genen auf das progressionsfreie Überleben von Patienten mit metastasiertem Kolorektalen Karzinom.
OeGHO- & AHOP-Frühjahrstagung 2018 ; APR 19 - 21, 2018; Villach, AUSTRIA. 2018. [Poster]

 

Smolle, MA; Van Praag, V; Posch, F; Bergovec, M; Heregger, R; Pichler, M; Gerger, A; Szkandera, J; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Van de Sande, M; Leithner, A Efficacy Of Metastasectomy For Metachronous Metastases Of Soft Tissue Sarcoma. A Bi-Centre Study Including 153 Patients.
Abstractbook of 19th EFORT. 2018; -19th EFORT Congress; MAY 30 - JUN 1, 2018; Barcelona, SPAIN. [Oral Communication]

 

Smolle, MA; van Praag, V; Posch, F; Bergovec; M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Jüttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Liegl-Atzwanger, B; Leithner, A Effect of metastasectomy on overall-survival of patients with metachronous metastasis of STS. A bi-centre study including 135 patients.
12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4-7, 2018; Jaipur, INDIA. 2018. [Poster]

 

Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MAJ; Leithner, A Metachronous metastasis of soft tissue sarcoma: Benefit of metastasectomy. A bi-centre study.
Abstractbook of the EMSOS 2018. 2018; -31st EMSOS Meeting; MAY 9-11, 2018; Amsterdam, THE NETHERLANDS. [Oral Communication]

 

Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Pabst, D; Schauer, S; Fackelmann, U; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Gerger, A; Schüler, J; Zühlsdorf, M; Höfler, G Case Report: Patient-derived xenograft model from multi-resistant prostate cancer.
Der Pathologe. 2018; 39(5):490-490.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

 

Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Role of frequent chr13 q12.2 amplification in colorectal cancer patients
Role of frequent chr13 q12.2 amplification in colorectal cancer patients. 2018; -11th International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE. [Poster]

 

Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

Gerger, A Potentielle Rolle von ctDNA im Therapiemanagement
Jahrestagung 2017 der DGHO, OeGHO, SGMO und SGH; Oct 2, 2017; Stuttgart. 2017. [Oral Communication]

 

Gerger, A Potential role of ctDNA in therapy management
ONCOL RES TREAT. 2017; 40: 193-193. [Oral Communication]
Web of Science

 

Leithner, A; Posch, F; Leitner, L; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Szkandera, J Local Recurrence, Distant Metastasis, and Death in Patients with Soft Tissue Sarcoma after Curative Resection Using a Multi-state Model.
Abstractbook of 19th General Meeting of ISOLS. 2017; -ISOLS 2017; MAY 10-12, 2017; Kanazawa, JAPAN. [Oral Communication]

 

Leitner, L; Posch, F; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Leithner, A; Szkandera, J; Lokalrezidiv-Rate, Metastasierung und Mortalität nach Resektion lokalisierter Weichteilsarkome in kurativer Intention: Ein multi-state Model.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY. [Oral Communication]

 

Martin Pichler, Stefanie Cerk, Daniela Schwarzenbacher, Armin Gerger, Jan Basri Adiprasito, Verena Stiegelbauer, Gerald Höfler, Herbert Stöger A novel long non-coding RNA, SCA-RNA1, is associated with aggressive biological behaviour and poor prognosis in breast cancer patients.
ÖGHO Frühjahrstagung; 2017. [Oral Communication]

 

Martin Pichler, Verena Stiegelbauer, Armin Gerger, Gerald Höfler, Johannes Haybaeck Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
2nd International Symposium on Frontiers in Molecular Science - Non-Coding RNAs and Epigenetics in Cancer; 2017. [Poster]

 

Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA. [Oral Communication]

 

Partl R, Posch F, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse
Abstractband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik ; OCT 6-7; Linz, AUSTRIA. [Poster]

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Doeller, C; Pichler, M; Gerger, A; Bezan, A; Stotz, M; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit Of Adjuvant Radiotherapy For Local Control, Distant Metastasis, And Survival Outcomes In Patients With Localised Soft-Tissue Sarcoma: Comparative Effectiveness Analysis Of An Observational Cohort Study.
Abstractbook of 18th EFORT Congress. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local Recurrence, Distant Metastasis, And Survival In Patients With Soft-Tissue Sarcoma (STS) After Curative Resection: A Multi-State Model.
Abstractbook of 18th EFORT Congress. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Poster]

 

Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T; The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText

 

Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY. [Oral Communication]

 

Stiegelbauer,V; Pehserl, AM;Deutsch,A;Adiprasito, JB; Stoeger, H; Haybaeck, J; Stotz, M; Hoefler, G; Gerger, A; Pichler, M; MicroRNA-196 blocks colorectal cancer cell migration and metastases formation through regulation of HOXB7 and GalNT5.
ÖGHO Frühjahrstagung; 2017. [Poster]

 

Verena Stiegelbauer, Armin Gerger, Gerald Höfler, Herbert Stöger, , Johannes Haybaeck, Michael Karbiener, Anna Pehserl, Michael Stotz, Martin Pichler MicroRNA-196 Influence Metastases Formation in Colorectal Cancer through Regulation of HOXB7 and GALNT5 Gene Expression
2nd International Symposium on Frontiers in Molecular Science - Non-Coding RNAs and Epigenetics in Cancer ; 2017. [Oral Communication]

 

Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Investigation of the role of frequent chr13 q12.2 focal amplification in colorectal cancer patients
17. Jahrestagung der Österreichischen Gesellschaft für Humangenetik (ÖGH); SEP 29, 2017; Graz, AUSTRIA . 2017. [Oral Communication]

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016. [Oral Communication]

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M; 23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY. [Oral Communication]
FullText

 

Gilg, MM; Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Berghold, A; Ferstl-Rohrbacher, A; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Poster]

 

Hofer, P; Bernina, S; Leeb, G; Hamann, M; Baiern, A; Mach, K; Bergmann, M; Gerger, A; Röter, K; Waldenberger, M; Meitinger, T; Strauch, M; Sieger, C; the KORA-Study Group; Frommlet, F; Gasur,A A genome-wide association study of CORSA identifies novel and confirms known genetic risk factors for advanced colorectal adenomas
Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology; Sep 12-14, 2016; Graz, Austria. 2016. [Poster]

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL. [Oral Communication]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016. [Oral Communication]

 

Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.41 [Poster]
Web of Science FullText FullText_MUG

 

Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Längle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Silina, K; Petrausch, U; Posch, F; Leibl, S; Mündlein, A; Moch, A; Siebenhüner, A; Stupp, A; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27: Doi: 10.1093/annonc/mdw393.12
Web of Science FullText FullText_MUG

 

Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion.
European Respiratory Journal 2016 48: PA3399. 2016; 48: -ERS International Congress ; SEP 3-7, 2016; London, UNITED KINGDOM. [Poster]
FullText

 

Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion
EUR RESPIR J. 2016; 48: Doi: 10.1183/13993003.congress-2016.PA3399
Web of Science FullText FullText_MUG

 

Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773. [Poster]
Web of Science

 

Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL. [Poster]

 

Smolle, MA; Pichler, M; Flick, H; Olschewski, H; Lindenmann, J; Samonigg, H; Gerger, A. Einfluss von nicht-steroidalen Antirheumatica (NSARs) sowie Laborparametern auf den Erfolg einer chemischen Pleurodese bei malignen Pleuraergüssen.
European Surgery, Supplement 1 Abstracts 57th Annual Meeting of the Austrian Society of Surgery. 2016; 48(1):46-46.-57. Österreichischer Chirurgenkongress; MAY 25- 27, 2016; Salzburg, AUSTRIA. [Oral Communication]

 

Stiegelbauer, V; Schwarzenbacher, D; Pehserl, A, Adiprasito, JB, Deutsch, A; Stöger, H; Haybaeck, J; Stotz, M; Höfler, G; Gerger, A; Pichler, M MicroRNA196 regulates metastases formation in colorectal cancer
8th ÖGMBT Annual Meeting; SEP 12-14, 2016; Graz. 2016. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Conditional survival of patients with soft tissue sarcoma (STS) after curative Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Thomas Winder, Michael Stotz, Alexander Rheinhard Siebenhuener, Konstantin Schlick, Teresa Magnes, Panagiotis Samaras, Joanna Szkandera, Pierre-Alain Clavien, Daniel Neureiter, Richard Greil, Bernhard C. Pestalozzi, Armin Gerger, Alexander Egle, Martin Pichler The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients
ASCO 2016. 2016; -ASCO; JUN 3-7, 2016; Chicago, USA. [Poster]

 

Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

Zhou, Q; Perakis, S; Ulz, P; Heitzer, E; Pichler,M; Gerger, A; Bauernhofer, T; Geigl, JB; Speicher, MR Monitoring targeted therapy response by cell-free circulating tumor DNA in metastatic colorectal cancer
Doctoral day; DEC 14, 2016; Graz, Austria. 2016. [Poster]

 

Benhaim, L; Zhang, W; Wakatsuki, T; Gerger, A; Yang, DY; Paez, D; Ning, Y; El-Khoueiry, RE; Loupakis, F; Bohanes, PO; Stintzing, S; Heinemann, V; Lenz, HJ Genetic variants of kinases suppressors of Ras (KSR) to predict tumor response to first-line cetuximab in patients with mCRC: Prospective analysis in the FIRE 3 trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.3613 [Poster]
Web of Science FullText FullText_MUG

 

Gerger, A Lebensqualität bei PatientInnen mit Pankreaskarzinom
Jahrestagung der Österreichischen Gesellschaft für Hämatologie und medizinische Onkologie; April 23-25, 2015; Salzburg. 2015. [Oral Communication]

 

Kainhofer, V; Szkandera, J; Smolle, M; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A; How wide should an R0 resection be in soft tissue sarcoma surgery?
Scientific Posters of ISOLS 2015; 10695. 2015; -ISOLS & MSTS; OCT 6-10, 2015; Orlando, FLORIDA. [Poster]

 

Krenn-Pilko, S; Langsenlehner, U; Thurner, E; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer.
BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0960-9776(15)70261-4 [Poster]
Web of Science FullText FullText_MUG

 

Renner, W; Gerger, A Colorektalkarzinom – Mutationsmarker und Pharmakogenetik zur Therapieentscheidung
2. Wörthersee Schnittstellensymposium Klinische Labormedizin; NOV 13-14, 2015; Klagenfurt, AUSTRIA. 2015. [Oral Communication]

 

Ress, Anna Lena; Stiegelbauer, Verena; Schwarzenbacher, Daniela; Deutsch, Alexander; Ling,Hui; Calin, George; Rinner, Beate; Gerger, Armin; Samonigg, Hellmut; Pichler, Martin. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
. 2015; -Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25.04; Salzburg. [Poster]

 

Rief, P; Pichler, M; Hafner, F; Gerger, A; Eller, P; Hackl, G; Brodmann, M; Gary, T De Ritis Score und CLI
Z f Gefäßmedizin. 2015; -Sailersymposium; Jun 18-19, 2015; Graz. [Poster]

 

S. Krenn-Pilko, U. Langsenlehner, E.-M. Thurner, T. Stojakovic, M. Pichler, A. Gerger, K.S. Kapp, T. Langsenlehner An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer
Poster and Abstract search Forum. 2015; -2015 St. Gallen Breast Cancer Conference; MAR 18-21, 2015; Vienna. [Poster]
FullText

 

S. Krenn-Pilko, U. Langsenlehner, E.M. Thurner, T. Stojakovic, M. Pichler, A. Gerger, K.S. Kapp, T. Langsenlehner External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients
Radiotherapy and Oncology, Journal of the European Society for Radiotherapy and Oncology. 2015; 115(1):356-356.-3rd ESTRO Forum Barcelona; APR 24-28, 2015; Barcelona. [Poster]
FullText

 

Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Gerger, A; Hofler, G; Rinner, B; Pichler, M Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer
ANN ONCOL. IMPAKT Breast Cancer Conference. 2015; 26: -IMPAKT Breast Cancer Conference; MAY 07-09, 2015; Brussels, BELGIUM. Doi: 10.1093/annonc/mdv120.6 [Poster]
Web of Science FullText FullText_MUG

 

Stotz, M; Herzog, SA; Pichler, M; Szkandera, J; Schaberl-Moser, R; Samonigg, H; Renner, W; Berghold, A; Gerger, A; Cancer stem cell gene variants and colon cancer prognosis.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25, 2015; Salzburg. 2015. [Poster]

 

Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA. [Oral Communication]
FullText

 

V. Stiegelbauer, A. Ress, D. Schwarzenbacher, A. Deutsch, S. Perakis, H. Ling, C. Ivan, G. Calin, A. Gerger, B. Rinner and M. Pichler The role of the putative tumor suppressor protein spinophilin in colorectal cancer
Ann Oncol (2015) 26 (suppl 4): iv64 doi:10.1093/annonc/mdv233.216 . 2015; -ESMO World Congress on Gastrointestinal Cancer; JUL 1-4, 2015; Barcelona, Spain. [Poster]

 

Bezan, A; Hutterer, G; Stöckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M; Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma partients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014. [Poster]

 

Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M BUN und CLI
DGA; Hamburg. 2014. [Oral Communication]

 

Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich H; Eller, P; Pilger, E; Brodmann, M NLR und PLR und der Zusammenhang mit der kritischen Extremitätenischämie
DGA ; Hamburg. 2014. [Keynote lecture]

 

Gerger, A Zielgerichtete Therapie beim Kolorektalkarzinom
IV. Interdisziplinäres Mayerlinger Onkologiesymposium ; Sep 12, 2013; Mayerling, Austria. 2014. [Keynote lecture]

 

Gerger, A Prädiktive Biomarker beim Kolorektalkarzinom
Jahrestagung der ÖGHO; April 10-12, 2014; Innsbruck. 2014. [Oral Communication]

 

Gerger, A Prädiktive Biomarker beim Kolorektalkarzinom
Kärntner und Steirisches Onkologiesymposium; May 23-25, 2014; Bad Kleinkirchheim. 2014. [Oral Communication]

 

Gerger A Neue Entwicklungen zur Behandlung von Lebermetastasen - wohin geht die Reise aus Sicht des Medizinischen Onkologen?
ÖGIM; Sep 25-27, 2014; Salzburg. 2014. [Oral Communication]

 

Hutterer, GC; Stöckigt, C; Stojakovic, T; Martín Hernández, JM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M High pre-operative monocyte-lymphocyte ratio (MLR) represents a poor prognostic factor in non-metastatic clear cell renal cell carcinoma
Eur Urol Suppl 2014;13;e320. 2014; -29th Annual EAU (European Association of Urology) Congress ; APR 11-15; Stockholm, SE. [Poster]

 

Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A LOCAL RECURRENCES OF SOFT TISSUE SARCOMAS: R-CLASSIFICATION VERSUS UICC-CLASSIFICATION OF RESECTION MARGINS.
Abstracts of CTOS 2014 Annual Meeting, P 253. 2014; 293--CTOS 2014 Annual Meeting; OCT 15-18, 2014; Berlin, GERMANY. [Poster]

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A Local recurrences after resection of soft tissue sarcomas: a multifactorial analysis.
Abstractbook of EMSOS 2014, 02.02. 2014; 9--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Oral Communication]

 

Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients
EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

Krenn-Pilko S., Langsenlehner U., Thurner E.-M., Stojakovic T., Pichler M., Gerger A., Kapp K.S., Langsenlehner T. Der präoperativ erhöhte Plasma-Fibrinogen-Spiegel ist als prädiktiver Faktor für die Prognose von Brustkrebs Patientinnen
Abstractband ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik. 2014; -ÖGRO / BAYRO 2014. 2014; -31. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik; OKT 3-4, 2014; Innsbruck, AUSTRIA. [Poster]

 

Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T; Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients.
STRAHLENTHER ONKOL. 2014; 190: 26-26.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Oral Communication]
Web of Science

 

Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 ) [Oral Communication]
Web of Science

 

Stotz, M; Pichler, M; Bezan, A; Peinsith, H; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative C-reactive protein (CRP) and fibrinogen level predicts clinical outcome in patients with stage III colon cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Abstractbook of EMSOS 2014, P02.04. 2014; 44--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Jahrestagung der DGHO, ÖGHO, SGMO und SGH ; OKT 10-14, 2014; Hamburg, Deutschland. 2014. [Oral Communication]

 

Thurner, EM; Krenn-Pilko, S; Gerger, A; Pichler, M; Kapp, KS; Langsenlehner, U; Langsenlehner, T The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients
ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T C-reaktives Protein (CRP) als prognostischer Marker bei nicht metastasierten Prostata Karzinompatienten.
Abstract-Band DEGRO 2014 Strahlentherapie und Onkologie. 2014; 190 (1):-20. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; Jul 3-6, 2014; Düsseldorf, Germany . [Poster]

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T; Relation between Polymorphisms in the Apoptotic Genes FAS and FASL and radiogenic Long-Terms-Effects in Prostate Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):127-127.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, K; Langsenlehner, T C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients
STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Poster]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Elevated C-reactive protein level predicts poor prognosis in prostate cancer patients treated with radiotherapy.
Journal of the European Society for Radiotherapy and Oncology.. 2014; 111(Supp 1):129-129.-ESTRO 33; APR 4-8, 2014; Vienna, AUSTRIA. [Oral Communication]

 

Belaj, K; Gary, T; Pichler, M; Eller, P; Hackl, G; Hafner, F; Gerger, A; Froehlich, H; Pilger, E; Brodmann, M Lymphocyte-to-Monocyte Ratio: A Novel Marker for Critical Limb Ischemia in PAOD Patients
Zeitschrift für Gefäßmedizin 2013. 2013; -Sailersymposium 2013; Jun 20-21, 2013; Graz. [Poster]

 

Benhaim, L; Gerger, A; Bohanes, PO; Paez, D; Wakatsuki, T; Yang, D; Labonte, MJ; Zhang, W; Ning, Y; Loupakis, F; El-Khoueiry, R; Laurent-Puig, P; Lenz, H-J Gender-specific profiling in SCN1A polymorphisms and time to recurrence in patients with stage II/III colorectal cancer
Journal of Clinical Oncology. 2013; 30(34):-2013 Gastrointestinal Cancers Symposium; Jan 24-26, 2013; San Francisco, USA. [Poster]

 

El-Khoueiry, RE; Wakatsuki, T; Ning, Y; Zhang, W; Yang, D; Azuma, M; Gerger, A; Stotz, M; Labonte, MJ; Wilson, PMD; Volz, NB; Stintzing, S; Maus, MKH; Sunakawa, Y; Koizumi, W; Watanabe, M; Li, JE; Barzi, A; El-Khoueiry, AB; Lenz, HJ Association of transcription factor 7-like 2 (TCF7L2) polymorphisms with worse survival in three independent cohorts from the United States, Austria, and Japan in patients with gastric cancer.
ASCO 2013; May 31-June 4, 2013; Chicago. 2013. [Poster]

 

Gary, T; Pichler, M; Belaj, K; Rief, P; Eller, P; Hafner, F; Gerger, A; Froehlich, H; Haas, E; Brodmann, M Lymphocyte to Monocyte Ratio: A novel marker for critical limb ischemia in PAOD patients
Vasa. 2013; -Dreiländertagung Angiologie Graz; Sep 15-18, 2013; Graz. [Oral Communication]

 

Gerger, A Predictive biomarkers in metastatic colorectal cancer
Industry; Sep 12, 2013; Vienna, Austria. 2013. [Keynote lecture]

 

Gerger, A RAS-mutations and Anti-EGFR in mCRC
Industry; 18.10.2013; Vienna, Austria. 2013. [Keynote lecture]

 

Gerger; A mCRC Update 2013
Industry; Oct 24, 2013; Fuerstenfeld, Austria. 2013. [Keynote lecture]

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Kielhauser, S; Gerger, A; Absenger, G; Glehr, M; Szkandera, J; Samonigg, H; Krippl, P; Renner, W Association of a common single nucleotide polymorphism in the TRAIL-R1 gene with relapse-free survival in rectal cancer patients.
Annals of Oncology. 2013; 24, Suppl. 4: iv51-iv52.-ESMO 15th World Congress on Gastrointestinal Cancer; JULY, 3-6, 2013; Barcelona, SPAIN. (ISBN: 0923-7534 ) [Poster]

 

Hutterer, GC; Pichler, M; Stöckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of patients with renal cell carcinoma
Proceedings book of the 2013 Genitourinary Cancers Symposium;194. 2013; -2013 Genitourinary Cancers Symposium: A Transformative Multidisciplinary Approach; FEB 14-16, 2013; Orlando, FL. [Poster]

 

Iqbal, S; Wakatsuki, T; Bohanes, PO; Zhang, W; Gerger, A; Azuma, M; Stotz, M; Yang, D; Ning, Y; Volz, NB; Stintzing, S; El-Khoueiry, RE; Labonte, MJ; Li, JE; Maus, MKH; Koizumi, W; Watanabe, M; Barzi, A; Lenz, HJ; El-Khoueiry, AB Iiteglin alpha4 (ITG alpha4) rs7562325 polymorphism was associated with better survivals in Austrian but not in Japanese patients with gastric cancer.
ASCO 2013; May 31-June 4, 2013; Chicago. 2013. [Poster]

 

Jesche, J; Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R Evaluierung der Wertigkeit der präoperativen Neutrophilen-/Lymphozyten-Ratio als Prognosefaktor bezüglich des krebsspezifischen-, metastasenfreien- und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House; 2013. DOI:10.3205/13oegu061. 2013; -39. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung, Graz; 06.-08.06.2013; Graz. [Poster]

 

Krenn-Pilko, S; Hofmann, G; Renner, W; Gerger, A; Thurner, EM; Kapp, KS; Langsenlehner, U; Langsenlehner, T Die präoperative Thrombozyten/Lymphozyten Ratio ist ein prädiktiver Faktor für die Prognose von Brustkrebspatientinnen
Abstractband ÖGRO 2013 . 2013; -ÖGRO ; SEP 18-19, 2013; Bregenz, AUSTRIA. [Poster]

 

Krenn-Pilko, S; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T The Relationship between VEGF Gene polymorphisms and Haplotypes with the Development of Distant metastases in postmenopausal Breast cancer patients
STRAHLENTHER ONKOL. . 2013; 189(2):182-183.-29th Annual Meeting of the Austrian-Society-of-Radiation-Oncology-Radiobiology-and-Medical-Radiophysics (OGRO); SEP 28-29, 2012; Gnunden, AUSTRIA. [Poster]
Web of Science

 

Labonte, MJ; Wakatsuki, T; Zhang, W; Yang, D; Azuma, M; Gerger, A; Stotz, M; Ning, Y; Volz, NB; Stintzing, S; Li, JE; El-Khoueiry, RE; Wilson, PMD; Koizumi, W; Watanabe, M; Maus, MKH; Barzi, A; Iqbal, S; El-Khoueiry, AB; Lenz, HJ Prognostic outcome of gastric cancer patients with cancer stem cell SNPs in Asian versus western countries.
ASCO 2013; May 31-June 4, 2013; Chicago. 2013. [Poster]

 

Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Ehammer-Rosenkranz, A; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association between VEGF-A gene variants and clinical outcome in prostate cancer patients treated with definitive radiotherapy
Proceedings of the ECCO- The European Cancer Congress 2013. 2013; -ECCO- The European Cancer Congress 2013; SEP 27- OCT 1, 2013; Amsterdam , NETHERLANDS. [Poster]

 

Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Ehammer-Rosenkranz, A; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association between VEGF-A gene variants and clinical outcome in prostate cancer patients treated with definitive radiotherapy
EUR J CANCER. 2013; 49: S689-S689.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Zacherl, M; Renner, W; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P4:102. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg, H; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; PSR:110. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Oral Communication]

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg; H; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P6:101. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Szkandera, J; Absenger, G; Weissmueller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2
Journal of Clinical Oncology . 2013; 30(34):-2013 Gastrointestinal Cancers Symposium; Jan 24-26, 2013; San Francisco, USA. [Poster]

 

Szkandera, J; Absenger, G; Weissmueller, M; Stotz, M; Pichler, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A A common gene variant in AXIN2 predicts clinical outcome in stage II and III colon cancer
387 (A55). 2013; -ASCO GI; JAN 24-26, 2013; San Francisco, USA. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M VALIDATION OF THE PROGNOSTIC RELEVANCE OF PLASMA C-REACTIVE PROTEIN LEVELS IN SOFT TISSUE SARCOMA.
Abstracts of the 18th Annual Meeting CTOS, P 94. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Leithner, A; Gerger, A THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR CANCER-SPECIFIC; METASTASIS-FREE AND OVERALL SURVIVAL IN SOFT-TISSUE SARCOMA PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 93. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T Zusammenhang zwischen Polymorphismen in den Apoptosegenen FAS und FASL und radiogenen Spätfolgen bei Prostatakarzinompatienten.
Abstractband ÖGRO 2013 Bregenz. 2013; -30. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; SEP 18-19, 2013; Bregenz, AUSTRIA. [Poster]

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Genetic variants in DNA repair genes and radiation-induced late toxicity in prostate cancer patients
EUR J CANCER. 2013; 49: S693-S693.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Genetic variants in DNA repair genes and radiation-induced late toxicity in prostate cancer patients
Proceedings of the 17th European Cancer Congress. 2013; -European Cancer Congress; SEP 27 - OKT 1, 2013; Amsterdam. [Poster]

 

Thurner, EM; Renner, W; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Single nucleotide polymorphisms in the RAD51, BRCA1 and BRCA2 genes and radiation-induced morbidity in prostate cancer patients.
Proceedings of the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. 2013; -13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology; JUN 22-24, 2013; Ermatingen, Switzerland. [Poster]

 

Winder, T; Szkandera, J; Absenger, G; Weismüller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Samonigg, H; Gerger, A A functional germline variant in Hedgheog pathway gene GLI1 identifies patients at high risk of tumor recurrence in stage II and III colon cancer
http://worldgicancer.com/WCGI/WGIC2013/. 2013; -World Congress on Gastrointestinal Cancer; July 3-6, 2013; Barcelona, Spain. [Oral Communication]

 

Absenger, G; Szkandera, J; Weissmüller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, H; Gerger, A The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer
Onkologie - International Journal for Cancer Research and Treatment. 2012; 35(6):55-56.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgard, Germany. [Poster]

 

Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A; The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER; [Poster]
Web of Science

 

Eisner, F; Pichler, M; Gerger, A; Schaberl-Moser, R; Samonigg, H 49 Monate Progressions-freies Überleben bei einem Patienten mit metastasiertem Kolonkarzinom unter Avastin- Erhaltungstherapie – Ein Fallbericht
Frühjahrstagung der Österreichischen Gesellschaft für Hämtologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Gerger, A Pharmacogenetic angiogenesis profiling for anti-VEGF therapies in metastatic colorectal cancer
Forschungsfeld Krebsforschung; Nov 26, 2012; Graz, Austria. 2012. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W; COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

Krenn-Pilko, S; Hofmann, G; Renner, W; Gerger, A; Thurner, EM; Kapp, KS; Langsenlehner, U; Langsenlehner, T The Role of VEGF Gene Polymorphisms in the Development of Distant Metastases in Postmenopausal Breast Cancer Patients
EUR J CANCER. .... 2012; 48(1):S184-S185.-8th European Breast Cancer Conference (EBCC); MAR 21-24, 2012; Vienna, AUSTRIA. [Poster]
Web of Science

 

Krenn-Pilko, S; Hofmann, G; Renner, W; Gerger, A; Thurner, EM; Kapp, KS; Langsenlehner, U; Langsenlehner, T The role of VEGF Gene Polymorphism in the development of distant metastases in postmenopausal Breast cancer patients.
Strahlentherapie und Onkologie. 2012. 2012; 188(1):65-65.-Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY. (ISBN: 0179-7158 ) [Poster]
Web of Science

 

Krenn-Pilko, S; Thurner, EM; Absenger, G; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T; Association Between Variants in the VEGF Gene and Distant Metastases in Postmenopausal Breast Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012) Doi: 10.1016/S0959-8049(12)71726-4 [Poster]
Web of Science FullText FullText_MUG

 

Krenn-Pilko, S; Thurner, EM; Renner, W; Absenger, G; Gerger, A; Kapp, KS; Langsenlehner, T; Langsenlehner, U The Development of Distant Metastases in Postmenopausal Woman with Breast Cancer in Association with VEGF Gene Polymorphisms
EUR J CANCER. 2012; 48: 63-63.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND. Doi: 10.1016/S0959-8049(12)72008-7 [Poster]
Web of Science FullText FullText_MUG

 

Krenn-Pilko S., Thurner EM., Renner W., Gerger A., Kapp KS., Langsenlehner U., Langsenlehner T. Der Zusammenhang zwischen VEGF Genpolymorphismen und Haplotypen mit der Entwicklung von Fernmetastasen bei postmenopausalen Mammakarzinompatientinnen.
Abstractband ÖGRO 2012 Gmunden Toscana. 2012; 43-43.-ÖGRO 2012, Gmunden Toscana Kongress; Sep 28-29, 2012; Gmunden. [Poster]
FullText

 

Loupakis, F; Zhang, W; Gerger, A; Yang, D; Bohanes, PO; Labonte, MJ; Benhaim, L; Wakatsuki, T; Ning, Y; Wilson, PMD; El-Khoueiry, R; El-Khoueiry, AB; Iqbal, S; Barzi, A; Giamas, G; Stebbing, J; Lenz, HJ LMTK3 polymorphism in patients with metastatic colon cancer
J Clin Oncol 30, 2012 (suppl 4; abstr 471). 2012; -2012 Gastrointestinal Cancers Symposium ; Jan 2012; San Francisco, USA. [Poster]

 

Marx-Neuhold, EA; Zulus, B; Absenger, G; Szkandera, J; Schippinger, W; Gerger, A; Renner, W A common polymorphism in the promoter of the erythropoietin gene is associated with delayed onset of peripheral arterial disease.
Drug Metabolism and Drug Interactions. 2012; 27(3):39-39.-6th Santorini Conference Biologie Prospective; SEP 30-OKT 2, 2012; Thira, GREECE. [Poster]

 

Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A; A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Szkandera, J; Zulus, B; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional rs1617640 polymorphism in the promoter of the erythropoietin gene is not associated with susceptibility and outcome of early-stage breast cancer.
Drug Metabolism and Drug Interactions. 2012; 27(3):22-22.-6th Santorini Conference Biologie Prospective.; SEP 30-OKT 2, 2012; Thira, GREECE. [Poster]

 

Thurner, EM; Krenn-Pilko, S; Absenger, G; Hofmann, G; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Correlations between variants in the ERCC2 gene and the risk of the development of radiation induced late toxicity in prostate cancer patients
Onkologie - International Journal for Cancer Research and Treatment. 2012; 35(6):182-182.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie; OKT 19-23, 2012; Stuttgart, GERMANY. (ISBN: 978-3-318-02304-6 ) [Oral Communication]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Gerger, A; Hofmann, G; Renner, W; Langsenlehner, U; Kapp, K; Langsenlehner, T VEGF Genpolymorphismen als Risikofaktoren für das Auftreten von radiogenen Spätfolgen bei Prostatakarzinompatienten.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology. 2012; 5: 24-24.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, AUSTRIA. [Poster]

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T Genetic Variants in the TGF-beta 1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients
EUR J CANCER. 2012; 48: 87-87.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND. Doi: 10.1016/S0959-8049(12)72081-6 [Poster]
Web of Science FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Langsenlehner, U; Gerger, A; Kapp, KS; Langsenlehner, T Role of ERCC2 Gene polymorphisms in the development of radiation-induced Late effects in Prostate cancer patients.
Strahlentherapie und Onkologie. 2012; 188(1):107-107.-18. Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY. [Poster]
Web of Science

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Szkandera, J; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012) Doi: 10.1016/S0959-8049(12)71727-6 [Poster]
Web of Science FullText FullText_MUG

 

Wakatsuki, T; Bohanes, PO; Zhang, W; Gerger, A; Yang, D; Ning, Y; Winder, W; Labonte, MJ; Wilson, PMD; Benhaim, L; El-Khoueiry, R; El-Khoueiry, AB; Iqbal, S; Giamas, G; Stebbing, J; Lenz, HJ Use of genetic variants of LMTK3 to predict tumor recurrence in female localized gastric adenocarcinoma
J Clin Oncol 30, 2012 (suppl 4; abstr 63) . 2012; -2012 Gastrointestinal Cancers Symposium ; Jan 2012; San Francisco, USA. [Poster]

 

Zhang, W; Gerger, A; Labonte, MJ; Yang, D; Bohanes, PO; Ning, Y; Winder, T; Wilson, PMD; Benhaim, L; El-Khoueiry, R; El-Khoueiry, AB; Iqbal, S; Giamas, G; Stebbing,J; Lenz, HJ Association of gender-related tumor recurrence with a polymorphic variant of LMTK3 in stage II and III colon cancer
J Clin Oncol 30, 2012 (suppl 4; abstr 454) . 2012; -2012 Gastrointestinal Cancers Symposium ; Jan 2012; San Francisco, USA. [Poster]

 

D. Yang, L. Benhaim, W. Zhang, P. O. Bohanes, Y. Ning, A. Gerger, M. J. Labonte, S. G. Groshen, A. B. El-Khoueiry, S. Iqbal, H. Lenz Gender and cause-specific survival in patients with stage III colon cancer: A SEER study.
J Clin Oncol 29: 2011 (suppl; abstr e14006)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; Chicago. [Poster]

 

Gerger, A; Bohanes, PO; Yang, D; Winder, T; Ning, Y; Labonte, MJ; Mauro, DJ; Langer, C; Rowinsky, EK; Lenz, H-J Human epidermal growth factor receptor-2 (HER2) Ile655Val single nucleotide polymorphism (SNP) is associated with gender-specific outcome in patients with metastatic colorectal cancer (mCRC) treated with cetuximab in a phase II study (IMCL-0144)
J Clin Oncol 29: 2011 (suppl 4; abstr 441) 2011; -2011 Gastrointestinal Cancers Symposium ; Jan 20-22, 2011; San Francisco, CA, USA. [Poster]

 

Gerger, A; Zhang, W; Yang, D; Bohanes, PO; Ning, Y; Winder, T; Labonte, MJ; Wilson, PM; Benhaim, L; El-Khoueiry, R; Absenger, G; El-Khoueiry, AB; Iqbal, S; Lenz, H Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy.
J Clin Oncol 29: 2011 (suppl; abstr 3592)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; Chicago. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Bitsche, S; Absenger, G; Samonigg, H; Krippl, P; Renner, W RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS
ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND. [Poster]
Web of Science

 

L. Benhaim, A. Gerger, W. Zhang, D. Yang, P. O. Bohanes, Y. Ning, T. Winder, M. J. Labonte, P. M. Wilson, R. El-Khoueiry, A. B. El-Khoueiry, S. Iqbal, H. Lenz Cancer stem cell gene variants associated with colon cancer recurrence.
J Clin Oncol 29: 2011 (suppl; abstr 3612)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; Chicago, USA. [Poster]

 

M. J. Labonte, D. Yang, W. Zhang, P. M. Wilson, A. Gerger, P. O. Bohanes, Y. Ning, L. Benhaim, R. El-Khoueiry, Y. M. Nagarwala, A. M. Kemner, M. J. Pishvaian, R. K. Hsieh, O. Gladkov, S. Urba, S. Y. Rha, D. Sakaeva, S. Iqbal, A. B. El-Khoueiry, H. Lenz Use of MTHFR A1298C polymorphism to predict response in a phase II international clinical trial of patients with advanced gastric (GC) or gastroesophageal junction (GEJ) adenocarcinoma treated with first-line lapatinib plus capecitabine.
J Clin Oncol 29: 2011 (suppl; abstr 4076)2011; -2011 ASCO Annual Meeting; 3-7, 2011; Chicago. [Poster]

 

P. M. Wilson, P. O. Bohanes, C. J. Rankin, J. K. Benedetti, C. M. Ulrich, S. R. Smalley, K. W. Makar, W. Zhang, T. Winder, Y. Ning, A. Gerger, L. Benhaim, R. El-Khoueiry, M. J. Labonte, C. D. Blanke, H. Lenz The final results of the SWOG S9304 phase III intergroup trial’s pharmacogenetic analysis: Association of polymorphisms with survival and toxicity in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation (RT).
J Clin Oncol 29: 2011 (suppl; abstr 3542)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; chicago. [Poster]

 

R. D. Ladner, W. Zhang, M. J. Labonte, D. Yang, Y. Ning, A. Gerger, P. O. Bohanes, T. Winder, A. B. El-Khoueiry, S. Iqbal, N. Petasis, H. Lenz Prediction of tumor recurrence in stage II colon cancer through genetic variants in formyl peptide receptor 2 (FPR2).
J Clin Oncol 29: 2011 (suppl; abstr 3604)2011; -2011 ASCO Annual Meeting; Jun 3-7, Jun; Chicago. [Poster]

 

S. Iqbal, M. J. Labonte, D. Yang, W. Zhang, P. O. Bohanes, Y. Ning, L. Benhaim, R. El-Khoueiry, P. M. Wilson, A. Gerger, A. B. El-Khoueiry, H. Lenz Polymorphisms in EGF a+61G, GSTP1 Ile105Val, and MTHFR A1298C to predict response and survival in a phase II study for patients with metastatic or unresectable gastric (G) or gastroesophageal junction (GEJ) cancer treated with capecitabine, oxaliplatin (XELOX), and cetuximab.
J Clin Oncol 29: 2011 (suppl; abstr 4121)2011; -2011 ASCO Annual Meeting; 3-7, 2011; Chicago. [Poster]

 

T. Winder, G. Giamas, W. Zhang, D. Yang, P. O. Bohanes, Y. Ning, A. Gerger, M. J. Labonte, J. Stebbing, H. Lenz Use of insulin-like growth factor (IGF) pathway polymorphism IGF1R_rs2016347 to predict tumor recurrence in estrogen receptor–positive breast cancer patients.
J Clin Oncol 2011; 29: 2011 (suppl; abs: -2011 ASCO Annual Meeting; 3-7, 2011; Chicago. [Poster]

 

Thurner, EM; Renner, W; Hofmann, G; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Die Rolle von Polymorphismen in DNA-Reparaturgenen in der Entwicklung von radiogenen Nebenwirkungen bei Prostatakarzinompatienten.
STRAHLENTHER ONKOL. 2011; 187(1):78--27. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik (ÖGRO); NOV 19-20 2010; Krems, AUSTRIA. [Oral Communication]

 

Thurner, EM; Renner, W; Hofmann, G; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Side effects - Prevention and Management.
STRAHLENTHER ONKOL. 2011; 187(1):78-78. [Oral Communication]
Web of Science

 

Thurner, EM; Renner, W; Langsenlehner, U; Gerger, A; Hofmann, G; Kapp, K; Langsenlehner, T CORRELATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS IN THE XRCC1 GENE AND THE RISK OF SEVERE SIDE EFFECTS AFTER RADIOTHERAPY FOR PROSTATE CANCER
RADIOTHER ONCOL. 2011; 99: S351-S351. Doi: 10.1016/S0167-8140(11)71035-0
Web of Science FullText FullText_MUG

 

Thurner, EM; Renner, W; Langsenlehner, U; Gerger, A; Hofmann, G; Kapp, KS; Langsenlehner, T CORRELATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS IN THE XRCC1 GENE AND THE RISK OF SEVERE SIDE EFFECTS AFTER RADIOTHERAPY FOR PROSTATE CANCER.
Radiotherapy and Oncology. 2011; 99: 351-351.-ESTRO Anniversary Congress; MAY 8-12, 2011; London, UK. [Poster]

 

W. Zhang, D. Yang, C. Harbison, S. Khambata-Ford, D. P. Malone, Y. Ning, P. O. Bohanes, A. Gerger, M. J. Labonte, L. Benhaim, A. B. El-Khoueiry, S. Iqbal, H. Lenz FCGR2A H131R and FCGR3A V158F polymorphism status in mCRC patients treated with single-agent cetuximab (IMCL 0144 and CA225045) or with second-line irinotecan plus cetuximab (EPIC): A pooled statistical analysis.
J Clin Oncol 29: 2011 (suppl; abstr e14025)2011; -2011 ASCO Annual Meeting; Jun 3-7, 2011; Chicago. [Poster]

 

Y. Ning, W. Zhang, D. Yang, D. Weber, F. Souami, P. O. Bohanes, A. Gerger, M. J. Labonte, L. Benhaim, H. Lenz Analysis of polymorphisms in sodium channel, voltage-gated, type I, alpha subunit (SCN1A) as predictors of clinical outcome and toxicity in advanced ovarian cancer patients enrolled in a phase III trial treated with patupilone.
J Clin Oncol 29: 2011 (suppl; abstr 5051)2011; -2011 ASCO Annual Meeting; 3-7, 2011; Chicago. [Poster]

 

Zhang, W; Labonte, MJ; Yang, D; Ning, Y; Gerger, A; Bohanes, PO; Winder, T; El-Khoueiry, A; Iqbal, S; Lenz, H-J Use of genetic variants in formyl peptide receptor 2 (FPR2) to predict tumor recurrence in stage II colon cancer
J Clin Oncol 29: 2011 (suppl 4; abstr 408) 2011; -2011 Gastrointestinal Cancers Symposium ; Jan 20-22; San Francisco, CA, USA. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Bitsche, S; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W Hereditary variants of VEGF receptor genes and their impact on overall survival in rectal cancer.
Onkologie2010; 33(S 6):174-174.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W ASSOCIATION OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRINS WITH METASTASIS-FREE SURVIVAL IN RECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):59-59.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W COMMON VEGF RECEPTOR GENE POLYMORPHISMS AND THEIR INFLUENCE ON OVERALL SURVIVAL IN COLORECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):35-35.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Szkandera, J; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W Association of a single nucleotide polymorphism in the gene of TNFRSF10A (TRAILR-1) with relapse-free survival in colorectal cancer.
Onkologie2010; 33(S 6):173-173.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. (ISBN: 0378-584X ) [Poster]
Web of Science

 

Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

Knechtel, G; 1, Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A; Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
MEMO Suppl 01/10; 2010; 16-17.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T Elevated plasma fibrinogen level represents an independent prognostic factor in breast cancer patients.
Radiotherapy and Oncology - Journal of the European Society for Radiotherapy and Oncology. 2010; 111: -European Society for Radiotherapy and Oncology 33; APR 4-8, 2014; Vienna, AUSTRIA. [Poster]

 

Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Assiciation of hypoxia inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
MEMO Suppl 01/10; 2010; 16-16.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g; Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA . [Poster]

 

Thurner, EM; Renner, W; Hofmann, G; Gerger, A; Partl, R; Langsenlehner, U; Kapp, KS; Langsenlehner, T Association between polymorphisms in DNA repair genes and the development of severe late side effects after radiotherapy in prostate cancer patients
memo - Magazine of European Medical Oncology (Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology) 2010; 3, Supplement 1: -ÖGHO Frühjahrstagung ; APRIL 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Ahlgrimm-Siess, V; El-Shabrawi-Caelen, L; Kopera, D; Richtig, E; Koller, S; Arzberger, E; Gerger, A; Smolle, J; Hofmann-Wellenhof, R RCM for pre- and postprocedure assessment of solar lentigines before and after treatment with a 694nm Q-switched ruby laser.
18th Congress of the European Academy of Dermatology and Venereology (EADV); Oct 7-11, 2009; Berlin, Germany. 2009. [Oral Communication]

 

Ahlgrimm-Siess, V; Massone, C; Fink-Puches, R; Richtig, E; Wolf, I; Koller, S; Gerger, A; Smolle, J; Hofmann-Wellenhof, R Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma – early features and signs of progression.
7th World Congress on Melanoma, 5th Congress of the European Association of Dermato-Oncology (EADO)2009; -7th World Congress on Melanoma, 5th Congress of the European Association of Dermato-Oncology (EADO); May 12-16th, 2009; Vienna, Austria. [Oral Communication]

 

Ahlgrimm-Siess, V; Massone, C; Scope, A; Fink-Puches, R; Richtig, E; Wolf, IH; Koller, S; Gerger, A; Smolle, J; Hofmann-Wellenhof, R Nicht-invasive Diagnose von Lentigo maligna und Lentigo maligna Melanomen im Gesichtsbereich mittels konfokaler Reflexionsmikroskopie
Jahrestagung der ÖGDV; NOV 27-29, 2009; Salzburg, Austria. 2009. [Poster]

 

Gerger, A Der dentogene Herd aus Sicht des Onkologen
ARGE für Orale Chirurgie, Medizin, Radiologie (OCMR); Juni 20, 2009; Graz, Austria. 2009. [Oral Communication]

 

Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langselnlehner, U Association of Interleukin-10 gene variation wit breast cancer prognosis
Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 14-16, 2009; Salzburg. 2009. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W Colorectal cancer survival and its association to a common hereditary polymorphism in the gene of Death Receptor 4 (TNFRSF10A)
MEMO Suppl 02/09; 2009; 2: 21-21.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W The 683A>C polymorphism in the ligand binding domain of TRAILR-1 (TNFRSF10A) is not associated with colorectal cancer survival.
Annals of Oncology2009; 20(S 7):31-31.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27, 2009; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W The FASL -844T>C polymorphism is not associated with metastasis-free survival in patients with colorectal cancer
MEMO Suppl 02/09; 2009; 2: 21-22.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W A common hereditary single nucleotide polymorphism in the FASL-gene and its impact on colorectal cancer survival.
Onkologie2009; 32(S 4):75-75.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg/Mannheim, GERMANY. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Genetic variants of integrin receptor genes are not associated with colorectal cancer survival
Onkologie2009; 32(S 4):75-75.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; OCT 2-6, 2009; Heidelberg/Mannheim, GERMANY. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W A hereditary single nucleotide polymorphism in the FAS gene and its impact on developing metastases in rectal cancer patients.
Annals of Oncology. 2009; 20(S 7):58-58.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27; Barcelona, SPAIN. [Poster]
Web of Science

 

Knechtel, G; Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U Analysis of common germline polymorphisms to predict metastasis in node-positive breast cancer
MEMO Suppl 02/09; 2009; 2: 20-21.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Koller, S; Lorber, A; Wiltgen, M; Ahlgrimm-Siess, V; Weger, W; Richtig, E; Smolle, J; Hofmann-Wellenhof, R; Gerger, A Correlation of image analysis features and visual morphology in melanocytic skin tumours using in vivo confocal scanning microscopy.
7th World Congress on Melanoma 5th Congress of the European Association of Dermato-Oncology (EADO)2009; 270-270.-7th World Congress on Melanoma 5th Congress of the European Association of Dermato-Oncology (EADO); MAY 12-16, 2009; Vienna, Austria. [Poster]

 

Koller, S; Wiltgen, M; Ahlgrimm-Siess, V; Weger, W; Richtig, E; Smolle, J; Hofmann-Wellenhof, R; Gerger, A IN VIVO CONFOCAL LASER-SCANNING MICROSCOPY OF MELANOCYTIC SKIN TUMOURS: DIAGNOSTIC APPLICABILITY USING UNSELECTED TUMOUR IMAGES
12th World Congress On Cancers of the Skin ; May 3-6, 2009; Tel Aviv, Israel . 2009. [Poster]

 

Koller, S; Wiltgen, M; Ahlgrimm-Siess, V; Weger, W; Richtig, E; Smolle, J; Hofmann-Wellenhof, R; Gerger, A Diagnostic image analysis of malignant melanoma in in-vivo confocal laser scanning microscopy - a preliminary study.
Abstracts on CD Rom 2009; -18th Congress of the European Academy of Dermatology and Venerology ; OCT 7-11, 2009; Berlin, GERMANY. [Poster]

 

Langsenlehner, T; Döller, C; Quehenberger, F; Hofmann G; Langsenlehner, U; Gerger, A; Kapp, K The role of radiotherapy in the treatment of locally advanced bladder cancer.
Onkologie2009; 32(S 4):222-222.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; OCT 2-6, 2009; Heidelberg/Mannheim, GERMANY. [Poster]

 

Langsenlehner, T; Hofmann, G; Gerger, A; Langsenlehner, U; Tauber, G; Partl, R; Kapp, KS Analysis of the association between single nucleotide polymorphisms and haplotypes in the VEGF gene and prostate cancer risk.
MEMO Suppl 02/09; 2009; 2: 26-26.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 14-16, 2009; Salzburg, AUSTRIA. [Poster]

 

Langsenlehner, T; Partl, R; Tauber, G; Gerger, A; Hofmann, G; Renner, W; Kapp, KS; Langsenlehner, U Single nucleotide polymorphisms in the gene for vascular endothelial growth factor and radiation induced late toxicity
EJC Supplements 20092009; 7(2):155-155.-Joint ECCO15-34th ESMO Multidisciplinary Congress; SEP 20-24, 2009; Berlin, GERMANY. Doi: 10.1016/S1359-6349(09)70528-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Weger, W; Gerger, A, Hofmann-Wellenhof, R CONFOCAL MICROSCOPY: UTILITY IN NMSC TREATMENT
Abstract on CD Rom2009; 86-86.-INTERNATIONAL CONGRESS OF DERMATOLOGY, PRAGUE 2009; May 20-24, 2009; PRAGUE, Czech Republic. [Oral Communication]

 

Ahlgrimm-Siess, V; Horn, M; Koller, S; Gerger, A; Hofmann-Wellenhof, R Use of in vivo confocal laser scanning microscopy for monitoring of superficial basal cell carcinoma after cryotherapy
EXP DERMATOL. 2008; 17(3):280-280.-ADF Jahrestagung; Feb 28- March 1, 2008; Erlangen, Deutschland. [Poster]
Web of Science

 

Ahlgrimm-Siess, V; Horn, M; Koller, S; Gerger, A; Hofmann-Wellenhof, R Follow-up of actinic keratoses after shave biopsy by reflectance confocal microscopy.
Abstract on CD-rom 2008; -5th EADV Spring Symposium2008; -5th EADV Spring Symposium; 5th EADV Spring Symposium; Istanbul, Turkey. [Oral Communication]

 

Ahlgrimm-Siess, V; Massone, C; Fink-Puches, R; Richtig, E; Wolf, I; Koller, S; Gerger, A; Smolle, J; Hofmann-Wellenhof, R RCM of lentigo maligna and early lentigo maligna melanoma of the face: signs of progression and correlation to dermoscopic structures.
17th EADV CONGRESS; 17-20th September, 2008; Paris, France. 2008. [Oral Communication]

 

Ahlgrimm-Siess, V; Massone, C; Koller, S; Fink-Puches, R; Richtig, E; Wolf, IH; Gerger A; Hofmann-Wellenhof, R In vivo confocal scanning laser microscopy of common nevi with globular, homogeneous and reticular pattern in dermoscopy
66.Jahrestagung der American Academy of Dermatology (AAD); 01.02.2008 - 05.02.2008; San Antonio, Texas, USA. 2008. [Oral Communication]

 

Gerger, A Bisphosphonat-induzierte Osteonekrose des Kiefers
7. Onkologische Wintergespräche in Loipersdorf; 18.-19.1.2008; Loipersdorf. 2008. [Oral Communication]

 

Gerger, A; Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A45-A45.-45.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; Sep 17-20, 2008; Graz, AUSTRIA.. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk
MEMO2008; Volume 1, Suppl 1: 5-5.-Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie; Apr 10-12, 2008; Innsbruck, AUSTRIA. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Hereditary gene polymorphisms of vascular endothelial growth factor and colorectal cancer.
ANN ONCOL. 2008; 19(S6):68-68.-10th World Congress on Gastrointestinal Cancer; JUNE 25-28, 2008; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common-670 A > G polymorphism in the gene of TNFRSF6 (FAS) with overall survival in colorectal cancer patients
ANN ONCOL. 2008; 19(S 6):68-68. [Oral Communication]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Szkandera, J; Krippl, P; Renner, W Colorectal cancer survival and its association to a hereditary polymorphism in the promoter-gene of FAS
MEMO2008; Volume 1, Suppl 1: 4-5.-Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 10-12, 2008; Innsbruck, AUSTRIA. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common -1377 G>A polymorphism in the gene of FAS (TNFRSF6) with metastasis-free survival in rectal cancer.
Onkologie 2008; 31 (suppl 4): 104-104.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA. [Poster]

 

Horn, M; Koller, S; Weger, W; Gerger, A; Kerl, H; Hofmann-Wellenhof, R Confocal laserscanning guided surgery in the therapy of dermatofibrosarcoma protuberans.
. 2008; 128(S1): S73-S73. [Poster]
Web of Science

 

Koller, S; Ahlgrimm-Siess, V; Gerger, A; Smolle, J; Hofmann-Wellenhof, R In vivo confocal laser-scanning microscopy of inflammatory skin diseases
EXP DERMATOL. 2008; 17(3):266-266.-ADF Jahrestagung; Feb 28-Mar 1, 2008; Erlangen, Deutschland. [Poster]
Web of Science

 

Richtig, E; Ahlgrimm-Siess Verena, Koller Silvia, Gerger Armin, Horn Michael, Hofmann-Wellenhof Rainer Follow-up of actinic keratoses after shave biopsy by reflectance confocal microscopy
17th Congress of the European Academy of Dermatology and Venerology; Sept 17-21, 2008; Paris. 2008. [Oral Communication]

 

Ahlgrimm-Siess, Verena; Horn, Michael; Koller, Silvia; Gerger, Armin; Hofmann-Wellenhof ,Rainer In vivo konfokale Laserscanmikroskopie zur Therapiekontrolle nach Kryotherapie superfizieller Basalzellkarzinome
Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie (ÖGDV); 30.11.-02.12.2007; Wien. 2007. [Oral Communication]

 

Ahlgrimm-Siess,V; Gerger A; Richtig E; Fink-Puches R; Wolf IH; Smolle J; Kerl H; Hofmann-Wellenhof R In vivo confocal scanning laser microscopy of benign globular, homogeneous and reticular nevi
JDDG2007; 5(9):847-848.-3. Deutscher Hautkrebstag und 17. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie; Sep 20-23, 2007; Regenburg, Germany. [Oral Communication]

 

Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Koller, S; Weger, W; Richtig, E; Horn, M; Samonigg, H; Smolle, J In vivo confocal laser-scanning microscopy: bringing melanoma histopathology to the bedside.
J Invest Dermatol; 2007; 127(S2):S49-S49.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk.
Supplement 121; 157(25):14-14.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria. [Poster]

 

Hofmann, G; Gerger, A; Weitzer, W; Eder, T; Fürst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U Association of common integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
Supplement 121; 157(25):18-18.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14; 2007; Vienna, Austria. [Poster]

 

Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fürst, F; Renner, W; Halm, M; Samonigg, H; Krippl, P; Langsenlehner, U Common integrin receptor gene polymorphisms and their impact on colorectal cancer susceptibility
Onkologie2007; 30(S 3):12-12.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 ) [Oral Communication]

 

Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Yazdani-Biuki, B; Renner, W; Fürst, F; Samonigg, H; Krippl, P; Langsenlehner, U Classification tree analysis of functional genetic polymorphisms predicts breast cancer risk
Onkologie2007; 30(S 3):52-52.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 ) [Oral Communication]

 

Hofmann, G; Krippl, P; Eder, T; Fürst, F; Gerger, A; Renner, W; Weitzer, W; Samonigg, H; Langsenlehner, U The hereditary 936 C/T polymorphism in the vascular endothelial growth factor gene is not associated with colorectal cancer susceptibility.
Supplement 121; 157(25):17-17.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria. [Poster]

 

Hofmann-Wellenhof, R; Ahlgrimm-Siess, V; Fink-Puches, R; Richtig, E; Wolf, IH; Gerger, A; Smolle, J; Kerl, H In vivo Confocal laser scanning microscopy of equivocal pigmented skin lesions
J INVEST DERMATOL. 2007; 127: S25-S25.-The 37th Meeting of the European Society for Dermatological Research (ESDR); 5-9 September 2007; Zürich. [Oral Communication]
Web of Science

 

Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R Diagnostic in vivo confocal laser-scanning microscopy of actinic keratoses
J INVEST DERMATOL. ; 127: S41-S41.-68th Annual Meeting of the Society for Investigative Dermatology; May 9-12, 2007; Los Angeles, USA. [Poster]
Web of Science

 

Horn, M; Gerger, A; Wiltgen, M; Langsenlehner, U; Hofmann-Wellenhof, R; Weger, W; Richtig, E; Samonigg, H; Smolle, J Diagnostic image analysis of malignant melanoma in in-vivo confocal laser-scanning microscopy.
J Invest Dermatol;2007; 127(S2):S91-S91.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

Horn, M; Koller, S; Gerger, A; Weger, W; Kerl, H; Smolle, J Confocal laser scanning guided surgery in foreign filler caused granulomas.
ASDS Annual Meeting 2007, Abstract on CD-Rom2007; -ASDS Annual Meeting; OCT 11-14, 2007; Chicago, USA. [Poster]

 

Koller, S; Ahlgrimm-Siess, V; Gerger, A; Smolle, J; Hofmann-Wellenhof R Konfokale Laserscanning-Mikroskopie entzündlicher Hauterkrankungen.
Abstractband der Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie 2007; -Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie ; NOV 30-Dec 2, 2007; Vienna, Austria. [Poster]

 

Langsenlehner, T; Gerger, A; Hofmann, G; Kapp, K; Langsenlehner, U The role of the common MTHFR 677C>T polymorphism for breast cancer susceptibility in premenopausal women
Onkologie2007; 30(S 3):94-94.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 ) [Oral Communication]

 

Langsenlehner, T; Gerger, A; Hofmann, G; Kapp, KS; Langsenlehner, U Genetic polymorphisms in the vascular endothelial growth factor (VEGF) gene and breast cancer risk
BREAST CANCER RES TREAT. 2007; 106: S286-S286.-SABCS; DEC 13-16, 2007; San Antonio, Texas, USA. [Oral Communication]
Web of Science

 

Langsenlehner, T; Hofmann, G; Gerger, A; Kapp, KS; Langsenlehner, U The association between the MTHFR 677C>T polymorphism and breast cancer risk in premenopausal women.
Eur J Cancer Supplements2007; 5(4):100-100.-ECCO 14; SEP 23-27, 2007; Barcelona, . [Oral Communication]
Web of Science

 

Weger, W; Gerger, A; Samonigg, H; Kränke, B; Salmhofer, W; Aberer, E Capecitabine-induced subacute cutaneous lupus erythematosus.
Wiener Medizinische Wochenschrift; 157(S121):34-34.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria. [Poster]

 

Gerger, A Konfokale Laserscan-Mikroskopie von melanozytären Hauttumoren und Basalzellkarzinom
20. Fortbildungswoche für praktische Dermatologie und Venerologie; 2006; München. 2006. [Oral Communication]

 

Gerger, A; Horn, M; Samonigg, H; Langsenlehner, U; Krippl, P; Kerl, H; Smolle, J Diagnostic virtual histopathology of untreated fresh specimens from squamous cell carcinoma using confocal laser-scanning microscopy
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Oral Communication]
Web of Science

 

Gerger, A; Kerl, H; Samonigg, H; Langsenlehner, U; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Poster]
Web of Science

 

Gerger, A; Koller, S; Weger, W; Richtig, E; Kerl, H; Samonigg, H; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8, 2006; Graz, AUSTRIA. 2006. [Keynote lecture]

 

Gerger, A; Samonigg, H; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
-Österreichische Gesellschaft für Hämato-Onkologie; April, 2006; Wels. [Poster]

 

Gerger, A; Smolle-Jüttner, F; Samonigg, H; Hegenbarth, K; Smolle, J Asymptomatic primary malignant melanoma of the esophagus
Österreichische Gesellschaft für Hämato-Onkologie; APR 2006; Wels. 2006. [Oral Communication]

 

Langsenlehner, U; Eder, T; Renner, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism increases breast cancer risk.
BREAST CANCER RES TREAT. 2006; 100: S251-S252.-29th Annual San Antonio Breast Cancer Symposium; DEC 14-17, 2006; San Antonio, USA. [Poster]
Web of Science

 

Langsenlehner, U; Eder,T; Weitzer, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P The homozygous cyclooxygenase-2 (PTGS2) 8473CC genotype is associated with breast cancer risk and estrogen receptor positivity.
Onkologie. 29(S3):127-127.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; NOV 4-8, 2006; Leipzig, GERMANY. (ISBN: 3-8055-8214-5 ) [Poster]

 

Langsenlehner, U; Hofmann, G; Eder, T; Weitzer, W; Gerger, A; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTG52) 8473T>C polymorphism increases breast cancer susceptibility.
236-236.-19th Meeting of the European Association for Cancer Research (EACR); JULY 1-4, 2006; Budapest, HUNGARY. [Poster]

 

Riederer, M; Richtig, E; Dandachi, N; Resel, M; Tockner, S; Gerger, A; Kerl, H; Samonigg, H; Bauernhofer, T Quantitative detection of circulating tumor cells in peripheral blood of melanoma patients using multimarker real-time PCR and immunomagnetic cell sorting: A preclinical evaluation
ZMF Day ; 24.11.06; Graz, Austria. 2006. [Poster]

 

Wiltgen, M; Gerger, A; Smolle, J Automatic discrimination of benign common nevi and malignant melanoma by use of features in spatial and frequency domain
European Notes in Medical Informatics; Vol II(2):63-68.-Medical Informatics in Europe (MIE) 2006; AUG 27-30, 2006; Maastricht, THE NETHERLANDS. [Poster]

 

Gerger, A; Horn, M; Koller, S; Weger, W; Massone, C; Leinweber, B; Kerl, H; Smolle, J Confocal examination of untreated fresh specimens from basal cell carcinoma: Implications for microscopically guided surgery
J INVEST DERMATOL 2005 125: A87-A87.
Web of Science

 

Gerger, A; Horn, M; Koller, S; Weger, W; Massone, C; Leinweber, B; Kerl, H; Smolle, J Confocal examination of untreated fresh specimens from basal cell carcinoma: implications for microscopically guided surgery.
10th World Congress on Cancers of the Skin 2005; -10th World Congress on Cancers of the Skin ; MAY 13-16, 2005; Vienna, Austria. [Poster]

 

Gerger, A; Koller, S; Kern,T; Massone, C; Steiger, K; Richtig, E; Kerl, H; Smolle, J Diagnostic Applicability of In Vivo Confocal Laser Scanning Microscopy in Melanocytic Skin Tumours
World Congress on Cancers of the Skin; Mai, 2005; Vienna, Austria. 2005. [Poster]

 

Smolle J, Gerger A, Kerl H In vivo konfokale Laserscan-Mikroskopie in der Diagnostik von Hauttumoren
43. Tagung der Deutschen Dermatologischen Gesellschaft; April, 2005; Dresden, Germany. 2005. [Keynote lecture]

 

Gerger, A; Bergthaler, P; Smolle, J An automated method for the quantification and fractal analysis of immunostaining
Arbeitsgemeinschaft Dermatologische Forschung ; Feb, 2004; Dresden, Germany. 2004. [Poster]

 

Gerger, A; Koller, S; Kern, T; Massone, C; Steiger, K; Richtig, E; Kerl, H; Smolle, J Konfokale in-vivo Laserscanmikroskopie in der Melanomdiagnostik.
Akt Dermatol2004; 30: 345--14. Jahrestagung der ADO; Oct 21-23, 2004; München. [Oral Communication]

 

Gerger A, Koller S, Kern T, Massone C, Steiger K, Richtig E, Kerl H,Smolle J. Konfokale in vivo-Laserscanmikroskopie in der Melanomdiagnostik.
Proceedings of the Arbeitsgemeinschaft Dermatologische Onkologie2004; -Arbeitsgemeinschaft Dermatologische Onkologie; October 18, 2004; München, GERMANY. [Oral Communication]

 

Gerger, A; Koller, S; Steiger, K; Massone, C; Kern, T; Richtig, E; Smolle, J Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors
J INVEST DERMATOL 2004 123: -.
Web of Science

 

Gerger, A; Koller, S; Steiger, K; Massone, C; Kern, T; Richtig, E; Smolle, J Diagnostic applicability of in vivo confocal Laser scanning microscopy in melanocytic skin tumors.
Proceedings of the meeting2004; -34th ESDR; Sept 9-11, 2004; Wien. [Poster]

 

Gerger, A; Smolle, J Image analysis in in vivo confocal laser scanning microscopy
Arbeitsgruppe Analytische Morphologie und Experimentelle Dermatoonkologie der Arbeitsgemeinschaft Dermatologische Forschung; Feb, 2004; Dresden, Germany. 2004. [Keynote lecture]

 

Gerger, A; Wiltgen, M; Smolle, J Tissue counter analysis - A novel tool for the fully automated analysis of complex tissue scenes
CYTOMETRY PART A 2004 59A: 39-40.
Web of Science

 

Gerger, A; Wiltgen, M; Smolle, J Tissue Counter Analysis – a novel tool for the fully automated analysis of complex tissue scenes
International Society for Analytical Cytology; Mai, 2004; Montpellier. 2004. [Poster]

 

Gruber, MJ; Richtig, E; Wackernagel, A; Koller, S; Gerger, A; Smolle, J Image enhancement using mathematical morphology in in vivo laser scanning microscopy of the skin.
Proceedings of the meeting2004; -ADF; Feb 26-28, 2004; Dresden. [Poster]

 

Kolm, I; Di Stefani, A; Zalaudek, I; Fink-Puches, R; Wolf, IH; Richtig, E; Gerger, A; Smolle, J; Kerl, H; Hofmann-Wellenhof, R Dermoscopic classification and follow-up of halo nevi
J INVEST DERMATOL 2004 123: 395-395.
Web of Science

 

Kolm, I; Di Stefani, A; Zalaudek, I; Fink-Puches, R; Wolf, IH; Richtig, E; Gerger, A; Smolle, J; Kerl, H; Hofmann-Wellenhof, R Dermoscopic classification and follow-up of Halo nevi.
Proceedings of the meeting2004; -34th ESDR; Sept 9-11, 2004; Wien. [Poster]

 

Smolle, J; Gerger, A Workshop: in vivo-Laser scanning microscopy
The 2nd Symposium on Advanced Techniques in Microscopy and Cellular Bioinformatics & 3. Jahrestagung der Österreichischen Gesellschaft für Zytometrie; April, 2004; Krems. 2004. [Oral Communication]

 

Smolle, J; Gerger, A Tissue Counter
The 2nd Symposium on Advanced Techniques in Microscopy and Cellular Bioinformatics & 3. Jahrestagung der Österreichischen Gesellschaft für Zytometrie; April 2004; Krems. 2004. [Oral Communication]

 

Smolle, J; Gerger, A In vivo-Mikroskopie von Hautveränderungen
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark: Blitzlichter einer modernen Dermatologie; Nov, 2004; Graz. 2004. [Keynote lecture]

 

Wiltgen, M; Gerger, A; Wagner, C; Smolle, J Tissue counter analysis as a method for the discrimination of benign common nevi and malignant melanoma
Jahrestagung der Deutschen Gesellschaft fuer Medizinische Informatik, Biometrie und Epidemiologie (gmds); Sept, 2004; 2004. [Keynote lecture]

 

Gerger, A; Smolle, J Automated Tissue Classification, Lesional Identification and Pattern Indication of Melanocytic Skin Tumors at the Microscopic Level
1st Joint Meeting: 14th International Congress for Bioengineering and the Skin and 8th Congress of the International Society for Skin Imaging; Mai, 2003; Hamburg, Germany. 2003. [Poster]

 

Gerger, A; Stolz, W; Pompl, R; Smolle, J Instanzbasiertes Lernen und Klassifikationsbäume in der automatisierten Auflichtmikroskopie
Arbeitsgruppe Analytische Morphologie und Experimentelle Dermatoonkologie der Arbeitsgemeinschaft Dermatologische Forschung; Feb, 2003; Frankfurt, Germany. 2003. [Keynote lecture]

 

Gerger, A; Stolz, W; Pompl, R; Smolle, J Dermatoscopic Images investigated with Morphometric Measurements by Tissue Counter Analysis
1st Joint Meeting: 14th International Congress for Bioengineering and the Skin and 8th Congress of the International Society for Skin Imaging; Mai, 2003; Hamburg, Germany. 2003. [Keynote lecture]

 

Smolle, J; Paar, G; Gerger, A; Lechner, G; Sidla, O Skin mapping using low cost stereo vision
14th International Congress for Bioengineering and the Skin and 8th Congress of the International Society for Skin Imaging; Mai, 2003; Hamburg, Germany. 2003. [Poster]

 

Wiltgen, M; Gerger, A; Smolle, J An approach to the discrimination of benign common nevi and malignant melanoma from two different views: Wavelet texture analysis versus Co-occurrence matrix
14th International Congress for Bioengineering and the Skin and 8th Congress of the International Society for Skin Imaging; Mai, 2003; Hamburg, Germany. 2003. [Oral Communication]

 

Wiltgen, M; Gerger; A; Smolle, J Tissue counter analysis as a tool for the discrimination of skin tumors: a survey of the method
Arbeitsgemeinschaft Dermatologische Forschung; Feb, 2003; Frankfurt, Germany. 2003. [Keynote lecture]

 

Gerger, A; Smolle, J Automated epiluminescence microscopy - tissue counter analysis using CART and 1-NN in the diagnosis of melanoma
EXP DERMATOL 2002 11: 607-608.
Web of Science

 

Gerger, A; Smolle, J Automated Epiluminescence Microscopy - Tissue Counter Analysis using CART and 1-NN in the Diagnosis of Melanoma
3rd European Symposium on Teledermatology; Nov, 2002; Graz, Austria. 2002. [Poster]

 

Gerger, A; Smolle, J Morphometric Diagnosis of Histologic Sections of Melanocytic Skin Tumors using Tissue Counter Analysis
International Society of Dermatopathology; Sep, 2002; Berlin, Germany. 2002. [Poster]

 

Gerger, A; Smolle, J Morphometric diagnosis of histologic sections of melanocytic skin tumors in automated image analysis
J INVEST DERMATOL 2002 119: 767-767.
Web of Science

 

Gerger, A; Smolle, J Diagnostische Gewebeelemente melanozytärer Hauttumoren in der automatischen Bildanalyse
Arbeitsgemeinschaft Dermatologische Forschung; März, 2002; Berlin, Germany. 2002. [Poster]

 

Gerger, A; Smolle, J Diagnostic Imaging of Histologic Sections of Melanocytic Skin Tumors using Tissue Counter Analysis
15th Heidelberg Cytometry Symposium (HCS) Annual Meeting of the German Society of Cytometry (DGfZ) and the German Cancer Research Center Heidelberg (DKFZ); Oct, 2002; Heidelberg, Germany. 2002. [Poster]

 

Gerger, A; Smolle, J Morphometric Diagnosis of Histologic Sections of Melanocytic Skin Tumors in Automated Image Analysis
European Society of Dermatological Research; Sep, 2002; Geneva. 2002. [Poster]

 

Gerger, A; Smolle, J „Tissue Counter“-Analyse in der dermatologischen Diagnostik
Arbeitsgruppe Analytische Morphologie und Experimentelle Dermatoonkologie der Arbeitsgemeinschaft Dermatologische Forschung; März, 2002; Berlin, Germany. 2002. [Keynote lecture]

 

Smolle, J; Gerger, A Workshop: Image Analysis
3rd European Symposium on Teledermatology; Nov, 2002; Graz, Austria. 2002. [Poster]

 

Smolle, J; Paar, G; Gerger, A; Lechner, G; Sidla, O Skin mapping using low cost stereo vision
J INVEST DERMATOL 2002 119: 766-766.
Web of Science

 

Wiltgen, M; Gerger, A; Smolle, J Tissue counter analysis: discrimination of benign common nevi and malignant melanoma with features from histogram and co-occurrence matrix
EXP DERMATOL, 11, 608-609, 0906-6705 Doi: 10.1034/j.1600-0625.2002.110613.x
Web of Science FullText FullText_MUG

 

Wiltgen, M; Gerger, A; Smolle, J Tissue counter analysis: Discrimination of benign common nevi and malignant melanoma with features from histogram and co-occurrence matrix
3rd European Symposium on Teledermatology; Nov, 2002; Graz, Austria. 2002. [Poster]

 

Smolle, J; Gerger, A Tissue counter analysis of tissue components in skin biopsies - Evaluation using CART (classification and regression trees)
J INVEST DERMATOL 2001 117: 791-791.
Web of Science

 

Smolle, J; Gerger, A; Kerl, H Tissue Counter Analysis of Tissue Components in Skin Biopsies - Evaluation using CART (Classification and Regression Trees)
European Society of Dermatological Research; Sep, 2001; Stockholm, Schweden. 2001. [Poster]

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint